Related Experiment Video
Updated: Apr 17, 2026
10:16
Generation of Two-color Antigen Microarrays for the Simultaneous Detection of IgG and IgM Autoantibodies
Published on: September 15, 2016
13.4K
Microarray-based identification of human antibodies against Staphylococcus aureus antigens
Peggy Kloppot1, Martina Selle2, Christian Kohler1
1Institut für Mikrobiologie, Universität Greifswald, Greifswald, Germany.
Proteomics. Clinical Applications
|February 14, 2015
Summary
Researchers identified key Staphylococcus aureus (S. aureus) antigens by analyzing immune responses in healthy individuals. This discovery could lead to new vaccines and diagnostic tools for S. aureus infections.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- High mortality rates associated with Staphylococcus aureus infections necessitate novel strategies for treatment and early detection.
- Understanding the adaptive immune response to S. aureus is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the adaptive immune response against Staphylococcus aureus antigens in healthy human volunteers.
- To identify immunogenic S. aureus antigens for potential vaccine or diagnostic marker development.
Main Methods:
- Development of a protein microarray featuring 44 S. aureus proteins utilizing ArrayStrip platform technology.
- Analysis of plasma samples from 15 S. aureus carriers and 15 noncarriers to profile antibody responses.
Main Results:
- Identification of 21 immunogenic S. aureus antigens, with seven recognized by antibodies in over 60% of samples, defining a core S. aureus immunome.
- Significantly lower levels of Staphylococcus aureus-specific serum immunoglobulin G (IgG) were observed in noncarriers compared to carriers.
- Specific antibodies against IsaA, SACOL0479, and SACOL0480 were less frequent and abundant in noncarriers.
Conclusions:
- The developed protein microarray enables comprehensive profiling of Staphylococcus aureus-specific antibody responses.
- The identified antigens hold potential for use as targets in future vaccine development or as diagnostic markers for S. aureus infections.
